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Abstract: Autonomic reflex ascertains cardiovascular homeostasis during standing. Impaired
autonomic reflex could lead to dizziness and falls while standing; this is prevalent in stroke survivors.
Pulse rate variability (PRV) has been utilized in the literature in lieu of heart rate variability (HRV) for
ambulatory and portable monitoring of autonomic reflex predominantly in young, healthy individuals.
Here, we compared the PRV with gold standard HRV for monitoring autonomic reflex in ischemic
stroke survivors. Continuous blood pressure and electrocardiography were acquired from ischemic
stroke survivors (64 ± 1 years) and age-matched controls (65 ± 2 years) during a 10-minute sit-to-stand
test. Beat-by-beat heart period (represented by RR and peak-to-peak (PP) intervals), systolic blood
pressure (SBP), diastolic blood pressure (DBP), and pulse arrival time (PAT), an indicator of arterial
stiffness, were derived. Time and frequency domain HRV (from RR intervals) and PRV (from PP
intervals) metrics were extracted. PAT was lower (248 ± 7 ms vs. 270 ± 8 ms, p < 0.05) suggesting
higher arterial stiffness in stroke survivors compared to controls during standing. Further, compared
to controls, the agreement between HRV and PRV was impaired in stroke survivors while standing.
The study outcomes suggest that caution should be exercised when considering PRV as a surrogate of
HRV for monitoring autonomic cardiovascular control while standing in stroke survivors.
Keywords: autonomic nervous system; baroreceptor reflex; sit-to-stand test
1. Introduction
Impairment in autonomic function is commonly observed following ischemic stroke [1–3].
Autonomic cardiovascular control is a vital mechanism which regulates blood pressure during
standing [4–6], the failure of which could cause dizziness and unexpected falls [7]. Falls that are
associated with the failure to regulate blood pressure during a standing position (orthostatic intolerance),
due to autonomic dysfunction, are prevalent in stroke survivors, which adversely affect their quality
of life [8–11]. The prevalence of stroke increases with age, and with the anticipated increase in older
persons in the future more incidents of stroke can be expected [12–14]. Therefore, the development of
a portable and cost-effective technology for the continuous monitoring of the autonomic reflex in an
ambulatory fashion can play a consequential role in the management of untoward effects of a stroke to
improve the quality of life of affected persons.
Change in posture from sitting/supine to standing challenges blood pressure homeostasis due to a
gravity-induced downward displacement of central blood volume [4,5]. Consequently, beat-to-beat
reduction in blood pressure is sensed by the baroreceptors localized in the aortic arch and carotid
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sinus, the reflex i.e. a neural mediated increase in sympathetic and decrease in the vagal activity of
the autonomic nervous system (ANS) causes an elevation in the heart rate and a systemic vascular
resistance to ascertain blood pressure homeostasis [15,16]. Electrocardiography (ECG) derived heart
rate variability (HRV), which reflects an ANS function, is widely utilized for the assessment of
autonomic control of blood pressure in a non-invasive fashion [17–20].
Photoplethysmography (PPG), a measure of changes in blood volume in the underlying vascular
bed of tissue, provides a cost-effective and portable application for the derivation of beat-by-beat
cardiac rhythm by placing a single sensor on the body and has the potential to facilitate ambulatory
application [21–23]. A similar application by using ECG is limited due to the requirement of several
electrode placements [24]. The continuously acquired blood pressure waveform is morphologically
similar to PPG (Figure 1), due to the similarity in the acquisition technique, and is also utilized for the
derivation of pulse rate variability (PRV) [25–29]. Therefore, the development of a system based on
PRV for continuous, portable, and ambulatory autonomic performance monitoring can be essential for
tracking the effectiveness of therapy to improve autonomic function during rehabilitation. Additionally,
it can be used at home for monitoring autonomic function post-rehabilitation and could alert the user
of potential falls associated with poor autonomic control of blood pressure i.e., orthostatic intolerance.
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no effect on blood pressure (SBP, p = 0.51; DBP, p = 0.22; MAP, p = 0.29) in controls (Figure 2B). 
However, the blood pressure increased (SBP, p = 0.04; DBP, p = 0.006; MAP, p = 0.007) in the stroke 
group during standing compared to sitting. The pulse arrival time (PAT) was lower both during 
sitting (p = 0.03) and standing (p = 0.04) in the stroke group compared to controls (Figure 2C); the 
stand test caused a decrease in PAT in both controls (p = 0.07) and stroke survivors (p = 0.09) (Figure 
2C). 
Figure 1. An example of simultaneously recorde ECG, finger blood pressure (BP), and finger
photoplethysmography (PPG). The RR, peak-to-peak (PP), and pulse arrival time (PAT) time series
were derived as sho n in the figure. Finger PPG, although not utilized in this research, is shown to
highlight morphological similarity wit finger bl d pres ure waveform.
PRV is demonstrated to be a good surrogate of HRV for assessment of the autonomic function in
the literature, where strong agr ement between HRV and PRV is shown; primarily in you g, healthy
participants during a resting condition [24,27,30–34], while oth studi s h v shown a decrease in the
agreement under physiological conditions that perturbs cardiovascular homeostasis (tilt test, exercise)
and disea e [22,27,32,35–38]. This underscores the existence f inconsistencies in PRV as a surrog te of
HRV with health and experimental conditions. Accordingly, a comprehensive investigation, utilizing
data from a group other than young and healthy and under physiological conditions beyond resting, is
warranted to gain acceptance of PRV as a surrogate of HRV for global application. In this study, we
compared the degree of agreement between HRV and PRV in stroke survivors and age-matched healthy
controls. Time and frequency domains metrics from the two variables (HRV or PRV) were derived
and compared during a rest and orthostatic challenge applied via the sit-to-stand test. Moreover, we
utilize pulse arrival time (PAT), which is inversely related to arterial stiffness [39], for the assessment of
the vascular tone of the two groups. Based on the observations in the literature, we hypothesized the
observation of an impairment in the agreement between HRV and PRV in stroke survivors, especially
during the stand phase of the sit-to-stand test.
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2. Materials and Methods
2.1. Experimental Protocol and Data Acquisition
The data utilized in this research is a part of cerebral vasoregulation in the elderly with a stroke
dataset, which is publicly available on the Physionet website [40,41]. The detailed experimental protocol
is summarized elsewhere [41]. Here, we briefly summarize the experimental protocol with respect
to this study. Data were recorded from 41 older persons (age: 64.4 ± 1.3 years, height: 1.67 ± 0.01 m,
weight: 77.6 ± 2.2 kgs, 21 females) with a history of ischemic stroke and 29 age-matched controls (age:
65 ± 2 years, height: 1.66 ± 0.01 m, weight: 76 ± 2.5 kgs, 15 females). The stroke group consisted of
participants with chronic large vessel ischemic infarctions in the middle cerebral artery (MCA), which
were confirmed by CT and MRI tests. At the time of recording, participants were at 6.1 ± 4.9 years
(mean ± SD) from the MCA infarction and were in a clinically stable condition; their neurological and
functional status were verified via their score on neurological exams i.e., the Modified Rankin Scales
(MRS < 4) and the National Institutes of Health Stroke Score (NIHSS < 5).
The control group had no clinical history of stroke or other cardiovascular and/or neurological
diseases. Participants with intracranial or subarachnoid hemorrhage, any acute or unstable medical
conditions, and the inability to follow the details of the experimental protocol were screened out
from the study. Participants with medical conditions such as diabetes, arrhythmias, and/or severe
hypertension (systolic blood pressure > 200 mmHg and/or diastolic blood pressure > 100 mmHg) were
also excluded from the study.
Participants enrolled in the stroke and control groups were admitted to the General Clinical
Research Center (GCRC) for 2 days overnight stay. Vital signs and demographic information (height
and weight) were measured by a trained GCRC nurse. Blood was drawn to obtain a lipid profile,
hematocrit, and a complete blood count. Antihypertensive medications were attenuated 5-days prior
to the study. The experimental protocol was approved by the research ethics board of Beth Israel
Deaconess Medical Center. All participants signed an informed consent form prior to data acquisition.
During the study, continuous electrocardiogram (ECG), finger blood pressure, and blood flow velocity
at the MCA (Doppler ultrasound) were measured simultaneously during the sit-to-stand test. ECG was
measured in a 3-lead configuration (Spacelab Medical, Issaquah, WA, USA). Blood pressure waveform
was continuously recorded with Finapres (Ohmeda Monitoring Systems, Englewood, CO, USA). The
data were acquired at a sampling rate of 500 Hz using Labview 6.0 and the National Instruments data
acquisition system (National Instruments Inc., Austin, TX, USA).
2.2. Data Processing
All acquired signals were low pass filtered prior to data processing. The QRS complexes were
detected from ECG using the Pan–Tompkins algorithm [42], RR interval was obtained as the time
difference between two adjacent QRS complexes. Beat-by-beat systolic blood pressure (SBP) was
obtained from continuous finger blood pressure as a maximum between adjacent QRS complexes.
Diastolic blood pressure (DBP) was obtained from continuous finger blood pressure as a minimum
value in blood pressure waveform between adjacent QRS complexes. Mean arterial pressure (MAP) was
obtained as MAP = 23 × DBP + 13 × SBP. The RR and peak-to-peak (PP) interval were obtained as a
time difference between two adjacent QRS complex and blood pressure peaks, respectively. Beat-by-beat
pulse arrival time (PAT) was obtained as a time difference between the blood pressure peak and the R
peak of ECG for each cardiac cycle. According to the recommendation in the literature [17,18], time
and frequency domain heart rate variability (HRV) and pulse rate variability (PRV) parameters were
derived from the ECG and blood pressure waveform, respectively, during 5-min of sitting and 5-min
of standing. The time and frequency domain parameters derived in this research are listed in Table 1
and explained here in detail [17].
Brain Sci. 2019, 9, 162 4 of 12
Table 1. Time and frequency domain metrics utilized in this research to compare the agreement between
heart rate variability (HRV) and pulse rate variability (PRV).
HRV/PRV Variables Domain
Mean RR/PP intervals (heart period, HP) Time
Standard deviation of RR/PP intervals (SDNN) Time
Root mean square of successive difference between adjacent intervals (RMSSD) Time
Standard deviation of successive difference between adjacent intervals (SDSD) Time
Percentage of adjacent RR/PP intervals that differ by more than 50 ms (pNN50) Time
Normalized Low-Frequency (LF (n.u.)) Frequency
Normalized High-Frequency (HF (n.u.)) Frequency
LF/HF Ratio Frequency
The RR and PP time series were interpolated using spline interpolation to create an evenly sampled
signal and resampled to 10 Hz with zero mean prior to frequency domain analysis of HRV and PRV. The
Welch power spectral density (PSD) of RR and PP was calculated in very low frequency (VLF, 0–0.04 Hz),
low frequency (LF, 0.04–0.15 Hz), and high frequency (HF, 0.15–0.4 Hz) bands [17]. Then normalized
power in the LF and HF bands was calculated as LF (n.u.) = LF
(LF + HF) , HF (n.u.) =
HF
(LF + HF) , and
from the two indices the LFHF ratio was calculated. The PSD was computed with a Hamming window
of size with 256 samples and 50% overlap. The Pearson correlation coefficient (R) was computed to
underscore the degree of agreement between HRV and PRV for the respective parameters for the two
groups (control/stroke) under two conditions (sit/stand). Data analysis was performed using MATLAB
(MathWorks Inc., Natick, MA, USA).
2.3. Statistical Analysis
Two-factor test of analysis of variance (ANOVA) was performed to highlight the differences in
the cardiovascular parameters (RR intervals, blood pressure, and PAT) with the condition (sit/stand)
and group (control/stroke). One-Factor ANOVA was conducted to account for the difference which
may exist between HRV and PRV. Results were considered significant at α = 0.05. However, given
the limited sample size of the study, the results at α = 0.10 are also discussed to highlight possible
trends. The statistical analysis was performed using IBM SPSS Statistics 23 software (IBM Corporation,
Armonk, NY). The results are presented as mean ± SE unless mentioned otherwise.
3. Results
To perform pairwise HRV and PRV comparisons, 29 controls and 29 stroke survivors (12 left side,
12 right side, 4 bilateral MCA infarction, and 1 unknown) were analyzed (first 29 of the group). The
signal morphology and the calculation of beat-by-beat RR, PP, and PAT using ECG and blood pressure
waveforms are outlined in Figure 1.
The mean values of RR intervals and blood pressure for the two groups under the two conditions
are summarized in Figure 2A,B, respectively. The RR intervals decreased significantly in both groups
during standing compared to sitting (Figure 2A). The stroke group had a lower value for RR intervals
during sitting (p < 0.001) and standing (p < 0.001) compared to controls. The stand test had no effect on
blood pressure (SBP, p = 0.51; DBP, p = 0.22; MAP, p = 0.29) in controls (Figure 2B). However, the blood
pressure increased (SBP, p = 0.04; DBP, p = 0.006; MAP, p = 0.007) in the stroke group during standing
compared to sitting. The pulse arrival time (PAT) was lower both during sitting (p = 0.03) and standing
(p = 0.04) in the stroke group compared to controls (Figure 2C); the stand test caused a decrease in PAT
in both controls (p = 0.07) and stroke survivors (p = 0.09) (Figure 2C).
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conditions. A deterioration in the correlation between HRV and PRV was observed in the stroke 
group compared to controls during sitting, and more so during standing for SDNN, RMSSD, and 
SDSD (Figure 3). Only a minor fluctuation in the correlation between the group and condition was 
observed for pNN50 (Figure 3). 
 
Figure 3. The degree of agreement, determined by computing the Pearson correlation 
coefficient, between HRV and PRV for different time domain features for the two groups 
(control/stroke) and conditions (sit/stand). 
In the frequency domain, the correlation was relatively higher during sitting compared to 
standing both in controls as well as in stroke survivors for LF, HF, and LF/HF (Figure 4). The stand 
test had a more adverse effect on stroke group compared to controls for LF (R = 0.78 vs. R = 0.83), HF 
(R = 0.78 vs. R = 0.83), and LF/HF (R = 0.69 vs. R = 0.78). 
Figure 2. The behavior of RR intervals (A), blood pressure (B), and PAT (C) with group (control/stroke)
and condition (sit/stand). The figure presents the distribution (mean ± SE) of control–sit (C–S),
control–stand (C–ST), stroke–sit (S–S), and stroke–stand (S–ST). † represents a significant difference
from sit (same group), while ‡ represents a significant difference from control (same condition).
The corr lation between HRV a PRV for different time domain features is summarized in
Figure 3. A high correlation (R > 0.95) for the heart period was observed in both groups under both
conditions. A deterioration in the correlation between HRV and PRV was observed in the stroke group
compared to controls during sitting, and more so during standing for SDNN, RMSSD, an SDSD
(Figure 3). Only a minor fluctuation in the correlation between the group and condition was observed
for pNN50 (Figure 3).
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between HRV and PRV for different time omain features for the two groups (control/stroke) and
conditi ns (sit/stand).
In the frequency domain, the correlation was relatively higher du ing s tting compared to standing
both in controls as well as in stroke survivors for LF, HF, and LF/HF (Figure 4). Th stand test had a
more a verse effect on stroke group compared to controls for LF (R = 0.78 vs. R = 0.83), HF (R = 0.78
vs. R = 0.83), and LF/HF (R = 0.69 vs. R = 0.78).
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Figure 4. The degree of agreement, determined by computing the Pearson correlation coefficient,
between HRV and PRV for different frequency domain features for the two groups (control/stroke) and
conditions (sit/stand).
The statistical comparison between HRV and PRV for both time and frequency domains is
summarized in Figures 5 and 6, respectively. In the time domain, the statistical difference between
HRV and PRV for pNN50 (p = 0.006) was observed in the stroke group during the standing phase
(Figure 5C). In the frequency domain, the differences between HRV and PRV were observed during the
standing phase in the stroke group for LF (p = 0.06), HF (p = 0.08), and LF/HF (p = 0.06) (Figure 5).
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Figure 5. Statistical comparison of HRV and PRV for two groups (control/stroke) and two conditions
(sit/stand) for different time domain measures i.e., heart period (A), SDNN (B), pNN50 (C), RMSSD (D),
and SDSD (E). The figure represents the distribution (mean ± SE) in control–sit (C–S), control–stand
(C–ST), stroke–sit (S–S), and stroke–stand (S–ST). The figure also lists the statistical p-value of
the comparison.
Brain Sci. 2019, 9, 162 7 of 12
Brain Sci. 2019, 9, x FOR PEER REVIEW 7 of 11 
 
Figure 6. Statistical comparison of HRV and PRV for the two groups (control/stroke) and 
the two conditions (sit/stand) for different frequency domain measures. The figure 
represents the distribution in control–sit (C–S), control–stand (C–ST), stroke–sit (S–S), and 
stroke–stand (S–ST). The figure also lists the statistical p-value of the comparison. 
4. Discussion 
Autonomic dysfunction is an adverse symptom experienced by stroke survivors and is majorly 
accountable for orthostatic intolerance and associated falls leading to incapacitation and poor quality 
of life. Pulse rate variability has the potential for a cost-effective, portable, and ambulatory 
application for continuous monitoring of autonomic cardiovascular control in stroke survivors, 
which can assist in the management and mitigation of debilitating effects of stroke. PRV is shown to 
be a good surrogate of HRV for monitoring cardiovascular control in young, healthy participants 
during a stationary condition (rest), however, its potential towards monitoring autonomic reflex in 
people with a history of neurological disorder under the physiological condition challenging 
cardiovascular homeostasis (such as standing) is not well investigated and requires special attention. 
In this article, we investigated the effect of ischemic stroke, a neurological condition known to 
adversely affect autonomic function, on the viability of PRV as a surrogate of HRV for monitoring 
autonomic cardiovascular control while standing. The primary finding of the study was a reduction 
in the agreement (both in time and frequency domains) between HRV and PRV during standing in 
the stroke survivors. The analysis outcome suggests that caution should be exercised when 
considering PRV as a surrogate of HRV for monitoring autonomic reflex during orthostatic 
challenges in the stroke survivors. 
To assess cardiovascular control, the alterations in RR intervals, SBP, DBP, and MAP were noted 
between the two groups during the sit-to-stand test. While both control (p = 0.012) and stroke (p = 
0.014) groups showed decrease in RR intervals (increase in heart rate) during the standing phase 
when compared to sitting, the stroke group had lower values for RR intervals (higher heart rate) 
while sitting (p < 0.001) as well as standing (p < 0.001) compared to controls. This suggests the resetting 
of arterial baroreceptors as a ramification of ischemic infarction, resulting in a higher resting heart 
rate. Reduced physical activity in stroke survivors could also have contributed towards a resetting of 
the resting heart rate to a higher value. No difference (p > 0.10) was observed in the sitting or standing 
blood pressure values between the control and stroke groups (Figure 2); nevertheless, with the 
application of stand test elevation in blood pressure (SBP, p = 0.04; DBP, p = 0.006; MAP, p = 0.007) 
values were observed only in the stroke group (Figure 2). This hints toward the different vascular 
reflexes which regulate cardiovascular function in stroke survivors compared to controls during the 
standing phase. Analysis of autonomic blood pressure regulatory controls via arterial baroreflex 
sensitivity can shed further light in this regard. 
The potential of PRV to be a surrogate of HRV is dependent on the peripheral blood flow, where 
the elasticity and stiffness of arteries plays a consequential role. In this regard, we utilized the concept 
of pulse arrival time (PAT), a marker of arterial stiffness, to highlight vascular alterations between 
Figure 6. Statistical comparison of HRV and PRV for the two groups (control/stroke) and the two
conditions (sit/stand) for normalized LF (A), normalized HF (B), LF/HF ratio (C). The figure represents
the distribution (mean± SE) in control–sit (C–S), control–stand (C–ST), stroke–sit (S–S), and stroke–stand
(S–ST). The figure also lists the statistical p-value of the comparison.
4. Discussion
Autonomic dysfunction is an adverse symptom experienced by stroke survivors and is majorly
accountable for orthostatic intolerance and associated falls leading to incapacitation and poor quality
of life. Pulse rate variability has the potential for a cost-effective, portable, and ambulatory application
for continuous monitoring of autonomic cardiovascular control in stroke survivors, which can assist in
the management and mitigation of debilitating effects of stroke. PRV is shown to be a good surrogate
of HRV for monitoring cardiovascular control in young, healthy participants during a stationary
condition (rest), however, its potential towards monitoring autonomic reflex in people with a history of
neurological disorder under the physiological condition challenging cardiovascular homeostasis (such
as standing) is not well investigated and requires special attention. In this article, we investigated the
effect of ischemic stroke, a neurological condition known to adversely affect autonomic function, on
the viability of PRV as a surrogate of HRV for monitoring autonomic cardiovascular control hile
standing. The primary finding of the study was a reduction in the agreement (both in time and
frequency domains) between HRV and PRV during standing in the stroke survivors. The analysis
outcome suggests that caution should be exercised when considering PRV as a surrogate of HRV for
monitoring autonomic reflex during orthostatic challenges in the stroke survivors.
To assess cardiovascular control, the alterations in RR intervals, SBP, DBP, and MAP were noted
between the two groups during the sit-to-stand test. While both control (p= 0.012) and stroke (p = 0.014)
groups showed decrease in RR intervals (increase in heart rate) during the standing phase when
compared to sitting, the stroke group had lower values for RR intervals (higher heart rate) while sitting
(p < 0.001) as well as standing (p < 0.001) compared to controls. This suggests the resetting of arterial
baroreceptors as a ramification of ischemic infarction, resulting in a higher resting heart rate. Reduced
physical activity in stroke survivors could also have contributed towards a resetting of the resting heart
rate to a higher value. No difference (p > 0.10) was observed in the sitting or standing blood pressure
values between the control and stroke groups (Figure 2); nevertheless, with the application of stand
test elevation in blood pressure (SBP, p = 0.04; DBP, p = 0.006; MAP, p = 0.007) values were observed
only in the stroke group (Figure 2). This hints toward the different vascular reflexes which regulate
cardiovascular function in stroke survivors compared to controls during the standing phase. Analysis
of autonomic blood pressure regulatory controls via arterial baroreflex sensitivity can shed further
light in this regard.
The potential of PRV to be a surrogate of HRV is dependent on the peripheral blood flow, where
the elasticity and stiffness of arteries plays a consequential role. In this regard, we utilized the concept
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of pulse arrival time (PAT), a marker of arterial stiffness, to highlight vascular alterations between the
groups under two conditions [39,43]. The stroke group had lower (266 ± 7 ms vs. 289 ± 7 ms, p = 0.03)
PAT values at rest compared to controls; this observation further highlights altered vascular behavior
compared to controls 6.1 ± 4.9 years (mean ± SD) post-incident. Further, during the stand test, while
both control (270 ± 7 ms vs. 289 ± 7 ms, p = 0.07) and stroke (248 ± 7 ms vs. 266 ± 7 ms, p = 0.09) groups
showed a decrease in PAT as a result of an increase in heart rate, the PAT in the stroke group was lower
(248 ± 7 ms vs. 270 ± 7 ms, p = 0.04) compared to controls while standing (Figure 2C), which further
underscored the differences in vascular behavior between the groups. Arterial stiffness is a recognized
risk factor for stroke [44]; lower PAT values in stroke survivors emphasize the existence of residual
effects of stroke on the vascular tone and could affect the blood flow, which may cause disagreement
between the electrical (ECG) and mechanical (BP waveform) systems for obtaining beat-by-beat cardiac
rhythm and requires future comprehensive investigation.
In accordance with the literature, we observed high agreement between the ECG and the blood
pressure derived heart period for both controls and stroke groups during the sitting phase (Figure 3).
During the standing phase, the correlation between the ECG and the blood pressure derived heart
period remain unchanged (>0.99) for controls; however, the correlation was reduced in the stroke
group (Figure 3). Nevertheless, no statistical difference was observed in the ECG or the blood pressure
derived heart period for either group during the two conditions (Figure 5A). This suggests that the
effect of healthy aging or neurological disorder is not likely to influence the capability of acquiring
heart period (or heart rate) from blood pressure waveforms during orthostatic challenge.
Further, the stroke group showed lower agreement between the ECG and the blood pressure
derived SDNN, where lower correlation during both sitting (R = 0.86 vs. 0.96) and standing
(R = 0.80 vs. 0.95) was observed in the stroke group compared to controls; this further accentuated
the loss rhythmic beat-by-beat fluctuation to ascertain cardiovascular homeostasis. Similarly, RMSSD
in the stroke group during both sitting (R = 0.86 vs. 0.97) and standing (R = 0.77 vs. 0.97) exhibited
lower agreement compared to controls. The ECG and the blood pressure derived pNN50 was lower
in both groups during both conditions, suggesting that pNN50 is likely to be affected by both aging
and neurological conditions, therefore, blood pressure derived pNN50 is not a good indicator for
autonomic cardiovascular control in such a group.
Frequency domain analysis of HRV and PRV can quantify the sympathetic activity (LF (n.u.)), vagal
or parasympathetic activity (HF (n.u.)), as well as the sympathovagal balance (LF/HF), accordingly,
providing vital information pertaining to the ANS influence on cardiovascular control under different
physiological conditions [17]. A high correlation (>0.95) between HRV and PRV during the sitting
phase was observed for both groups in the LF (n.u.), HF (n.u.), and LF/HF ratio. However, under the
influence of a orthostatic challenge (standing), the correlation between HRV and PRV was reduced both
in controls as well as in stroke groups with a more profound reduction in the stroke group, especially for
the LF/HF ratio (R = 0.69 vs. R = 0.78), see Figure 4. This observation suggests PRV derived frequency
domain parameters may not reliably indicate the dynamics of autonomic cardiovascular control during
an orthostatic challenge and caution should be exercised while utilizing PRV for the assessment of
autonomic cardiovascular control during orthostatic challenges beyond a young, healthy population.
The comparison of HRV and PRV via statistical analysis exhibited behavior analogous to correlation
analysis. In the time domain, for pNN50, a significant difference (p = 0.006) between HRV and PRV
was observed for the stroke group during the standing phase while in the control group no difference
(p = 0.22) for pNN50 was observed during the standing phase. During the sitting phase, although the
correlation between HRV and PRV was reduced in the stroke group compared to controls in the time
domain, no statistical difference (p > 0.10) in the time domain was observed between HRV and PRV
in the stroke group. In the frequency domain, no difference (p > 0.10) was observed between HRV
and PRV during the sitting or standing phases. However, in the stroke group, although there was no
difference (p > 0.10) between HRV and PRV during the sitting phase, a difference was observed for
LF (p = 0.08), HF (p = 0.08), and the LF/HF (p = 0.06) ratio during the standing phase (Figure 6). This
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observation led us to conclude that PRV fails to accurately reflect the sympathetic, parasympathetic, or
sympathovagal balance in the stroke group during standing.
5. Conclusions and Limitations
In conclusion, we observed disagreement between HRV and PRV in the stroke survivors during
the sitting phase (time domain via correlation analysis) as well as during the standing phase (frequency
domain via correlation and statistical analysis) compared to controls. This finding leads us to conclude
that PRV may not be a reliable surrogate of HRV for monitoring autonomic cardiovascular control while
standing, in people with a history of ischemic stroke. A tremendous amount of literature is focused on
quantifying the relationship (HRV vs. PRV) in young, healthy participants during resting conditions,
while when the same comparative relationship was studied in an unhealthy population, unfavorable
outcomes were observed [36–38]. Therefore, the system developed for monitoring effectiveness of
therapy to improve orthostatic tolerance in a rehabilitation center as well as for self-monitoring of
autonomic function at home post-rehabilitation based on PRV may be limited in effect in mitigating
falls related to orthostatic intolerance. Unfortunately, limited study exists which extends the HRV
and PRV comparison beyond a young, healthy population [45]. Accordingly, a comprehensive
investigation including the population with cardiovascular and/or neurological diseases is required to
ensure the global application of PRV for monitoring autonomic cardiovascular control with an aim
to mitigate the deleterious effect of aging or neurological disorder on day-to-day activity to improve
the quality of life. Moreover, the vascular tone of the study group should also be accounted for to
further our understanding regarding the agreement between electrical (electrocardiography) and
mechanical (blood pressure or photoplethysmography) signals utilized for the assessment of autonomic
cardiovascular control.
The limitation of the present work was the unavailability of simultaneous young, healthy data
under orthostatic challenge. Although it is demonstrated in the literature that a high degree of agreement
exists between the HRV and PRV during orthostatic challenges in young, healthy participants, it would
be beneficial to compare the three groups under the same experimental protocol to quantify the degree
of change in PRV associated with healthy aging and neurological conditions. Further, it should be
noted that PRV in this study was derived from continuous blood pressure waveform and not PPG,
as due to the similarity in blood pressure waveform and PPG (Figure 1), it was expected that the
conclusion would be analogous.
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